Summary
Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only.
The global Liposome Drug Delivery market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Liposomal Bupivacaine
Other Liposomals
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Johnson & Johnson
Gilead Sciences
Pacira
Sun Pharmaceutical
Luye Pharma
Sigma-Tau Group
Teva Pharmaceutical
Ipsen (Onivyde)
Fudan-Zhangjiang
CSPC
Novartis
Kingond Pharm
Shanghai New Asia
Spectrum Pharmaceuticals
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Fungal Infection Therapy
Cancer & Tumor Therapy
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
Interested in this report?
Get your sample now!
Table of Contents
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
1.1.2 Specifications
1.2 Market Segment
1.2.1 by Type
1.2.1.1 Liposomal Doxorubicin
1.2.1.2 Liposomal Amphoteracin B
1.2.1.3 Liposomal Paclitaxel
1.2.1.4 Liposomal Bupivacaine
1.2.1.5 Other Liposomals
1.2.2 by Application
1.2.2.1 Fungal Infection Therapy
1.2.2.2 Cancer & Tumor Therapy
1.2.2.3 Others
1.2.3 by Regions
2 Industry Chain
2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
2.3.1 SWOT
2.3.2 Dynamics
3 Environmental Analysis
3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry
4 Market Segmentation by Type
4.1 Market Size
4.1.1 Liposomal Doxorubicin Market, 2013-2018
4.1.2 Liposomal Amphoteracin B Market, 2013-2018
4.1.3 Liposomal Paclitaxel Market, 2013-2018
4.1.4 Liposomal Bupivacaine Market, 2013-2018
4.1.5 Other Liposomals Market, 2013-2018
4.2 Market Forecast
4.2.1 Liposomal Doxorubicin Market Forecast, 2019-2024
4.2.2 Liposomal Amphoteracin B Market Forecast, 2019-2024
4.2.3 Liposomal Paclitaxel Market Forecast, 2019-2024
4.2.4 Liposomal Bupivacaine Market Forecast, 2019-2024
4.2.5 Other Liposomals Market Forecast, 2019-2024
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Fungal Infection Therapy Market, 2013-2018
5.1.2 Cancer & Tumor Therapy Market, 2013-2018
5.1.3 Others Market, 2013-2018
5.2 Market Forecast
5.2.1 Fungal Infection Therapy Market Forecast, 2019-2024
5.2.2 Cancer & Tumor Therapy Market Forecast, 2019-2024
5.2.3 Others Market Forecast, 2019-2024
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2012-2018
6.1.1.2 Asia-Pacific Market by Type
6.1.1.3 Asia-Pacific Market by Application
6.1.2 North America
6.1.2.1 North America Market, 2012-2018
6.1.2.2 North America Market by Type
6.1.2.3 North America Market by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2012-2018
6.1.3.2 Europe Market by Type
6.1.3.3 Europe Market by Application
6.1.4 South America
6.1.4.1 South America Market, 2012-2018
6.1.4.2 South America Market by Type
6.1.4.3 South America Market by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2012-2018
6.1.5.2 Middle East & Africa Market by Type
6.1.5.3 Middle East & Africa Market by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2019-2024
6.2.2 North America Market Forecast, 2019-2024
6.2.3 Europe Market Forecast, 2019-2024
6.2.4 South America Market Forecast, 2019-2024
6.2.5 Middle East & Africa Market Forecast, 2019-2024
7 Market Competitive
7.1 Global Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel
8 Major Vendors
8.1 Johnson & Johnson
8.2 Gilead Sciences
8.3 Pacira
8.4 Sun Pharmaceutical
8.5 Luye Pharma
8.6 Sigma-Tau Group
8.7 Teva Pharmaceutical
8.8 Ipsen (Onivyde)
8.9 Fudan-Zhangjiang
8.10 CSPC
8.11 Novartis
8.12 Kingond Pharm
8.13 Shanghai New Asia
8.14 Spectrum Pharmaceuticals
9 Conclusion
Table Product Specifications of Liposome Drug Delivery
Table Products Segment of Liposome Drug Delivery
Table Liposomal Doxorubicin Overview
Table Liposomal Amphoteracin B Overview
Table Liposomal Paclitaxel Overview
Table Liposomal Bupivacaine Overview
Table Other Liposomals Overview
Table Global Liposome Drug Delivery Market by Type, 2011-2022 (USD Million)
Table Application Segment of Liposome Drug Delivery
Table Fungal Infection Therapy Overview
Table Cancer & Tumor Therapy Overview
Table Others Overview
Table Global Liposome Drug Delivery Market by Application, 2011-2022 (USD Million)
Table Global Liposome Drug Delivery Market by Region, 2011-2022 (USD Million)
Table Cost of Liposome Drug Delivery
Table Market Dynamics
Table Policy of Liposome Drug Delivery
Table GDP of Major Countries
Table Liposomal Doxorubicin CAGR by Revenue and Volume, 2012-2018
Table Liposomal Amphoteracin B CAGR by Revenue and Volume, 2012-2018
Table Liposomal Paclitaxel CAGR by Revenue and Volume, 2012-2018
Table Liposomal Bupivacaine CAGR by Revenue and Volume, 2012-2018
Table Other Liposomals CAGR by Revenue and Volume, 2012-2018
Table Liposomal Doxorubicin CAGR by Revenue and Volume, 2012-2024
Table Liposomal Amphoteracin B CAGR by Revenue and Volume, 2012-2024
Table Liposomal Paclitaxel CAGR by Revenue and Volume, 2012-2024
Table Liposomal Bupivacaine CAGR by Revenue and Volume, 2012-2024
Table Other Liposomals CAGR by Revenue and Volume, 2012-2024
Table Fungal Infection Therapy CAGR by Revenue and Volume, 2012-2018
Table Cancer & Tumor Therapy CAGR by Revenue and Volume, 2012-2018
Table Others CAGR by Revenue and Volume, 2012-2018
Table Global Liposome Drug Delivery Market by Vendors, 2012-2018 (USD Million)
Table Global Liposome Drug Delivery Market by Vendors, 2012-2018 (in Volume)
Table Global Liposome Drug Delivery Market Share by Vendors, 2012-2018 (USD Million)
Table Global Liposome Drug Delivery Market Share by Vendors, 2012-2018 (in Volume)
Table Price Factors List
Table Johnson & Johnson Profile List
Table Microecological Modulator Operating Data of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Gilead Sciences Profile List
Table Microecological Modulator Operating Data of Gilead Sciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pacira Profile List
Table Microecological Modulator Operating Data of Pacira (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sun Pharmaceutical Profile List
Table Microecological Modulator Operating Data of Sun Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Luye Pharma Profile List
Table Microecological Modulator Operating Data of Luye Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sigma-Tau Group Profile List
Table Microecological Modulator Operating Data of Sigma-Tau Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Pharmaceutical Profile List
Table Microecological Modulator Operating Data of Teva Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ipsen (Onivyde) Profile List
Table Microecological Modulator Operating Data of Ipsen (Onivyde) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Fudan-Zhangjiang Profile List
Table Microecological Modulator Operating Data of Fudan-Zhangjiang (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table CSPC Profile List
Table Microecological Modulator Operating Data of CSPC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Profile List
Table Microecological Modulator Operating Data of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Kingond Pharm Profile List
Table Microecological Modulator Operating Data of Kingond Pharm (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Shanghai New Asia Profile List
Table Microecological Modulator Operating Data of Shanghai New Asia (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Spectrum Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Spectrum Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Figure Liposome Drug Delivery Picture
Figure Industry Chain Structure of Liposome Drug Delivery
Figure SWOT of Liposome Drug Delivery
Figure Liposomal Doxorubicin Market Size and Growth, 2012-2018 (USD Million)
Figure Liposomal Doxorubicin Market Size and Growth, 2012-2018 (in Volume)
Figure Liposomal Amphoteracin B Market Size and Growth, 2012-2018 (USD Million)
Figure Liposomal Amphoteracin B Market Size and Growth, 2012-2018 (in Volume)
Figure Liposomal Paclitaxel Market Size and Growth, 2012-2018 (USD Million)
Figure Liposomal Paclitaxel Market Size and Growth, 2012-2018 (in Volume)
Figure Liposomal Bupivacaine Market Size and Growth, 2012-2018 (USD Million)
Figure Liposomal Bupivacaine Market Size and Growth, 2012-2018 (in Volume)
Figure Other Liposomals Market Size and Growth, 2012-2018 (USD Million)
Figure Other Liposomals Market Size and Growth, 2012-2018 (in Volume)
Figure Liposomal Doxorubicin Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Liposomal Doxorubicin Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Liposomal Amphoteracin B Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Liposomal Amphoteracin B Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Liposomal Paclitaxel Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Liposomal Paclitaxel Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Liposomal Bupivacaine Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Liposomal Bupivacaine Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Other Liposomals Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Other Liposomals Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Fungal Infection Therapy Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Cancer & Tumor Therapy Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Others Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Asia-Pacific Market Size and Growth, 2012-2018 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2012-2018 (in Volume)
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
Figure North America Market Size and Growth, 2012-2018 (USD Million)
Figure North America Market Size and Growth, 2012-2018 (in Volume)
Figure North America Market Size by Type
Figure North America Market Share by Type
Figure North America Market Size by Application
Figure North America Market Share by Application
Figure Europe Market Size and Growth, 2012-2018 (USD Million)
Figure Europe Market Size and Growth, 2012-2018 (in Volume)
Figure Europe Market Size by Type
Figure Europe Market Share by Type
Figure Europe Market Size by Application
Figure Europe Market Share by Application
Figure South America Market Size and Growth, 2012-2018 (USD Million)
Figure South America Market Size and Growth, 2012-2018 (in Volume)
Figure South America Market Size by Type
Figure South America Market Share by Type
Figure South America Market Size by Application
Figure South America Market Share by Application
Figure Middle East & Africa Market Size and Growth, 2012-2018 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2012-2018 (in Volume)
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
Figure Asia-Pacific Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure North America Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure North America Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Europe Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Europe Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure South America Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure South America Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Middle East & Africa Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Liposome Drug Delivery Market Concentration by Region
Figure Marketing Channels Overview
